Open AccessForecasting the impact of diabetes mellitus on tuberculosis disease incidence and mortality in India
Author(s) -
Susanne F. Awad,
Peijue Huangfu,
Houssein H. Ayoub,
Fiona Pearson,
Soha R. Dargham,
Julia Critchley,
Laith J Abu-Raddad
Publication year - 2019
Publication title -
journal of global health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.581
H-Index - 34
eISSN - 2047-2986
pISSN - 2047-2978
DOI - 10.7189/jogh.09.020415
Subject(s) - medicine , tuberculosis , incidence (geometry) , epidemiology , diabetes mellitus , context (archaeology) , population , demography , disease , mortality rate , environmental health , pathology , endocrinology , biology , paleontology , physics , sociology , optics
Background In context of the rapidly expanding diabetes mellitus (DM) epidemic in India and slowly declining tuberculosis (TB) incidence, we aimed to estimate the past, current, and future impact of DM on TB epidemiology. Methods An age-structured TB-DM dynamical mathematical model was developed and analyzed to assess the DM-on-TB impact. The model was calibrated using a literature review and meta-analyses. The DM-on-TB impact was analyzed using population attributable fraction metrics. Sensitivity analyses were conducted by accommodating less conservative effect sizes for the TB-DM interactions, by factoring the age-dependence of the TB-DM association, and by assuming different TB disease incidence rate trajectories. Results In 1990, 11.4% (95% uncertainty interval (UI) = 6.3%-14.4%) of new TB disease incident cases were attributed to DM. This proportion increased to 21.9% (95% UI = 12.1%-26.4%) in 2017, and 33.3% (95% UI = 19.0%-44.1%) in 2050. Similarly, in 1990, 14.5% (95% UI = 9.5%-18.2%) of TB-related deaths were attributed to DM. This proportion increased to 28.9% (95% UI = 18.9%-34.1%) in 2017, and 42.8% (95% UI = 28.7%-53.1%) in 2050. The largest impacts originated from the effects of DM on TB disease progression and infectiousness. Sensitivity analyses suggested that the impact could be even greater. Conclusions The burgeoning DM epidemic is predicted to become a leading driver of TB disease incidence and mortality over the coming decades. By 2050, at least one-third of TB incidence and almost half of TB mortality in India will be attributed to DM. This is likely generalizable to other Asian Pacific countries with similar TB-DM burdens. Targeting the impact of the increasing DM burden on TB control is critical to achieving the goal of TB elimination by 2050.